Pilot Study to Test the Effects of Arctiva on Mild to Moderate Eczema

Completed · Not applicable

Conditions studied: Atopic Dermatitis Eczema

In brief

Up to 30 participants with mild to moderate atopic dermatitis/eczema will be enrolled to apply study Investigational Product for 4 weeks.

Key facts

Study ID

NCT05918237

Run by

ClinOhio Research Services, LLC

People needed

30

Starts

2023-02-06

Expected to finish

2023-04-28

Last updated by the study team

2023-06-26

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Male and Female;18-75 years of age
• Have a clinical diagnosis of Mild to Moderate Eczema or Atopic Dermatitis
• Signed and dated written informed consent in accordance with Good Clinical Practice (GCP) and local legislation prior to the start of any screening procedure

You may not qualify if…

• Patients using topical corticosteroids steroidal creams and other agents within 7 days prior to first dose of trial Eczema treatment.
• Use of systemic corticosteroids or other agents for atopic dermatitis within 4 weeks prior to first dose of trial treatment.
• Active bacterial, viral, or fungal skin infections

Where it is running

• ClinOhio Research Services, LLC — Columbus, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.